aTyr Pharma Inc.

ATYR | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.50

$0 (-0.70%)

At close: Sep 4, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $49.37M

Enterprise Value $2.64M

Beta 0.52

Average Volume 2.58M

Shares Outstanding (Diluted) 98.07M

Shares Change YoY 8.82%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US0021202025

Price Performance

Price Change 1M -6.2%

Price Change 3M 12.5%

Price Change 6M -44.7%

Price Change YTD -34.5%

Price Change 1Y -90.9%

Price Change 3Y -71.3%

Price Change 5Y -71.3%

1M CAGR (ann.) 1.1%

1Y CAGR (ann.) -91.2%

5Y CAGR (ann.) N/A

All-Time CAGR -42.1%

Valuation

PE Ratio -0.81

Forward PE 19.46

PEG Ratio -0.03

Forward PEG N/A

PS Ratio 256.64

Forward PS 5.50

PB Ratio 1.00

P/FCF Ratio -0.89

P/Adj. FCF Ratio -0.82

P/OCF Ratio -0.89

EV/Sales 13.90

EV/EBIT -0.04

EV/EBITDA -0.05

EV/FCF -0.05

Earnings Yield -124.0%

FCF Yield -112.4%

Adj. FCF Yield -122.6%

Financial Health

Net Cash $57.42M

Total Debt $11.3M

Cash & Short-Term Investments $57.42M

Total Assets $69.83M

Current Ratio 5.12

Quick Ratio 5.12

Debt / Equity Ratio 0.23

Debt / EBITDA -0.19

Debt / FCF -0.21

OCF / Debt -4.83

Interest Coverage 0.00

Altman Z-Score -13.25

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin -11754.7%

Operating Profit Margin -33609.5%

EBITDA Margin -30812.6%

Net Profit Margin -32003.7%

FCF Margin -28852.1%

Adj. FCF Margin -31465.8%

SBC / Revenue 2613.7%

SBC Impact (per share) -9.1%

Returns

Return on Assets -87.1%

Return on Equity -95.6%

Return on Invested Capital -106.6%

Return on Capital Employed -109.3%

Return on Tangible Assets -87.1%

Historical Growth (CAGR)

Revenue CAGR 3Y -73.7%

Revenue CAGR 5Y -55.1%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 16.7%

EPS CAGR 5Y 11.0%

EPS CAGR 10Y 9.8%

FCF CAGR 3Y -14.2%

FCF CAGR 5Y -60.1%

FCF CAGR 10Y -6.6%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 10

EPS Growth Next 3Y 20.4%

Revenue Growth Next 3Y 654.3%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.11

EPS Growth Est (next Q) -57.7%

Revenue Est (next Q) $2.5M

Revenue Growth Est (next Q) 1215.8%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $5.13

Price Target Upside 926.0%

Cash Flow

Operating Cash Flow $-54.54M

Free Cash Flow $-54.82M

Adj. Free Cash Flow $-59.79M

FCF Per Share -$0.56

OCF Per Share -$0.56

OCF/S Ratio -28705.3%

Income Statement

Revenue $190K

Gross Profit $-22.33M

Operating Income $-63.86M

EBITDA $-58.54M

Net Income $-60.81M

EPS (Diluted) -$0.62

Revenue / Employee $3.39K

Profit / Employee $-1.09M

Employees 56